Related Experiment Video
Updated: Aug 24, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis
Désirée Bonci1, Michael Hahne, Nadia Felli
1Laboratory of Hematology and Oncology, Istituto Superiore di Sanità, Rome, Italy.
Abstract:
A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation. We investigated the role of APRIL in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation. APRIL is not expressed in CD34(+) progenitor cells from healthy donors, but it is massively up-regulated during the proliferative phase of megakaryocytic cell differentiation. Exogenous APRIL expression in primary cells increases megakaryocytic cell growth, suggesting that APRIL acts as a proliferative factor in megakaryocytopoiesis. More importantly, neutralization of endogenous APRIL was able to dramatically reduce megakaryocyte expansion and platelet production. Thus, our data provide evidence that APRIL acts as a growth factor for terminal megakaryocytopoiesis and may promote physiologic platelet production.
Insights
Proliferation-inducing ligand (APRIL) promotes megakaryocyte growth and platelet production. This study reveals APRIL
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- A proliferation-inducing ligand (APRIL) is a tumor necrosis factor family member.
- APRIL is implicated in tumor cell proliferation.
Purpose of the Study:
- Investigate the role of APRIL in megakaryocytopoiesis, the process of megakaryocyte development and platelet formation.
- Determine if APRIL influences megakaryocytic cell differentiation and proliferation.
Main Methods:
- Assessed APRIL expression in CD34(+) progenitor cells and during megakaryocytic differentiation.
- Studied the effect of exogenous APRIL expression on primary megakaryocytic cells.
- Neutralized endogenous APRIL to evaluate its impact on megakaryocyte expansion and platelet production.
Main Results:
- APRIL is not expressed in healthy CD34(+) progenitor cells but is upregulated during megakaryocytic differentiation.
- Exogenous APRIL enhances megakaryocytic cell growth.
- APRIL neutralization significantly reduces megakaryocyte expansion and platelet production.
Conclusions:
- APRIL acts as a growth factor in terminal megakaryocytopoiesis.
- APRIL promotes physiologic platelet production.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

